INHALE-3 Study's Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps -March 11, 2024 at 06:05 am EDT

Post-meal hyperglycemia was significantly reduced by 20% with inhaled insulin compared with rapid-acting insulin delivered through MDI or insulin pumpsSubjects utilizing inhaled insulin experienced a...

Related Keywords

United States ,American ,Kevin Kaiserman ,Christie Iacangelo ,Rose Alinaya ,Mannkind Corporation Nasdaq ,Mannkind Corporation ,Clinical Development ,University Of Washington ,American Diabetes Association ,Exchange Commission ,Corporate Communications ,Globenewswire Inc ,Facebook ,Linkedin ,International Conference On Advanced Technologies ,Scientific Sessions ,Kind Corporation ,Advanced Technologies ,Diabetes Treatment ,Teaching Chair ,Senior Vice President ,Medical Affairs ,Inhalation Powder ,Important Safety Information ,Full Prescribing Information ,Annual Report ,Investor Relations ,